IZAFE GROUP AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.222 SEK | +0.91% |
|
-1.77% | -22.92% |
| 04-26 | IZafe Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-15 | IZafe Group AB Announces Ida Almgren to Step Down as CFO , Effective June 18, 2024 | CI |
| Sales 2021 | 375K 34.67K 2.76M | Sales 2022 | 729K 67.41K 5.37M | Capitalization | 24.14M 2.23M 178M |
|---|---|---|---|---|---|
| Net income 2021 | -36M -3.33M -265M | Net income 2022 | -23M -2.13M -169M | EV / Sales 2021 | 116 x |
| Net cash position 2021 | 13.74M 1.27M 101M | Net Debt 2022 | 2.3M 212K 16.93M | EV / Sales 2022 | 36.3 x |
| P/E ratio 2021 |
-1.03
x | P/E ratio 2022 |
-0.99
x | Employees | 7 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 13.76% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.91% | ||
| 1 week | -1.77% | ||
| Current month | -3.06% | ||
| 1 month | +4.23% | ||
| 3 months | -21.00% | ||
| 6 months | -43.08% | ||
| Current year | -22.92% |
1 week
0.21
0.24
1 month
0.210.26
Current year
0.200.31
1 year
0.170.48
3 years
0.173.80
5 years
0.175.44
10 years
0.1718.80
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 39 | 31/12/18 | |
Ida Almgren
DFI | Director of Finance/CFO | - | 08/11/20 |
Erik Gillsbro
CTO | Chief Tech/Sci/R&D Officer | 33 | 31/12/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Björn Rosengren
CHM | Chairman | 82 | 13/06/13 |
Göran Hermansson
BRD | Director/Board Member | 71 | 31/12/18 |
Richard Wolff
BRD | Director/Board Member | 49 | 31/12/20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/05/24 | 0.222 | +0.91% | 114,160 |
| 02/05/24 | 0.22 | -3.93% | 717,765 |
| 30/04/24 | 0.229 | -2.97% | 138,717 |
| 29/04/24 | 0.236 | -1.67% | 69,596 |
| 26/04/24 | 0.24 | +6.19% | 763,757 |
Delayed Quote Nasdaq Stockholm, May 03, 2024 at 04:18 pm
More quotes
iZafe Group AB, formerly MediRatt AB, is a Sweden-based company that conducts research, development and marketing of medical products for medication and drug management. Its offering includes Dosell, a patented drug dispenser under development that can be used when medicating patients at home via remote monitoring; and MediKoll, an app that provides patients information about side effects, reactions and allergies linked to different types of medication. The Company operates in the pharmaceutical industry, hospitals and care homes, and Pharmacies and private healthcare markets. It is active globally.
Calendar
29/05/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -22.92% | 5.56M | |
| +7.84% | 218B | |
| +7.35% | 183B | |
| +13.04% | 134B | |
| +26.03% | 106B | |
| -1.33% | 61.12B | |
| +4.81% | 50.89B | |
| +0.30% | 40.3B | |
| +2.78% | 35.53B | |
| +26.14% | 32.05B |
- Stock Market
- Equities
- IZAFE B Stock
